id,registry,title,main_sponsor,study_type,intervention_type,phase,recruitment_status,allocation,start_date,primary_completion_date,doi,pmid,url,publication_date,pub_title,is_publication_2y,is_publication_5y
NCT00359918,ClinicalTrials.gov,Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI),Other,Interventional,Drug,Phase 4,Completed,Randomized,2006-08-01,2009-08-01,10.1016/j.jcin.2011.01.013,21700245,https://www.ncbi.nlm.nih.gov/pubmed/21700245?dopt=Abstract,2011-06-01,Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction),TRUE,TRUE
NCT01049607,ClinicalTrials.gov,Stapler Hepatectomy for Elective Liver Resection,Other,Interventional,Procedure,Phase 3,Completed,Randomized,2010-01-01,2011-10-01,10.1002/bjs.9387,24402888,http://onlinelibrary.wiley.com/doi/10.1002/bjs.9387/abstract,2014-02-01,Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection,TRUE,TRUE
NCT01225380,ClinicalTrials.gov,"A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C",Industry,Interventional,Drug,Phase 2,Completed,Randomized,2010-10-01,2013-01-01,10.1002/hep.27836,25847509,https://www.ncbi.nlm.nih.gov/pubmed/25847509,2012-05-20,Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed,TRUE,TRUE
NCT01651832,ClinicalTrials.gov,Supportive Cancer Care Networkers (SCAN),Other,Interventional,Behavioral,NA,Completed,Randomized,2012-07-01,2015-12-01,10.1016/j.zefq.2014.06.012,26028456,https://zefq-journal.com/article/S1865921714001330/abstract,2015-01-01,[Trans-sectoral care for patients with colorectal cancer: Design of a prospective randomized controlled multi-center trial (FKZ 01GY1143)],TRUE,TRUE
NCT01486329,ClinicalTrials.gov,"VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer",Industry,Interventional,Biological,Phase 1,Completed,Randomized,2011-12-01,2014-10-01,10.1080/2162402x.2014.1001217,26137397,https://pubmed.ncbi.nlm.nih.gov/26137397/,2015-04-27,"Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial",TRUE,TRUE
